SmartTRAK is pleased to welcome Anikó Szekér, the newest addition to our Wound Care team. Anikó has 10+ years of medical device experience in Wound Care and Surgical single use products. Before joining SmartTRAK, Anikó was Marketing Manager, Eastern Europe Wound Care and Surgical at Mölnlycke Health Care.
3 min read
Meet Anikó Szekér - Senior Analyst, Wound Care
By Lindsey Wolejko on 1/9/20 9:43 AM
8 min read
SmartTRAK Seeking an Enterprise Sales Executive
By Sharon O'Reilly on 1/8/20 12:58 PM
Location: Northeast region of US (NY, NJ, MA, PA)
Full-time Position
Position:
BioMedGPS, a leading strategic advisory and healthcare analytics firm serving the life sciences industry, is seeking a Director of Enterprise Sales with extensive healthcare B2B experience for its SmartTRAK Business Intelligence platform and related products. Applicant must reside in the Northeastern region of the USA for easy access to major accounts.
SmartTRAK is the first business intelligence portal that provides real time data, analytics and curated content by a team of industry experts to help medical device executives make more informed strategic decisions. SmartTRAK is utilized by leading medical device companies within the orthopedic, wound care, regenerative medicine and neuro therapeutic areas. The Director of Sales will be responsible for selling SmartTRAK’s suite of business intelligence solutions to C- suite and other senior level executives, as well as building long term strategic programs and relationships at all levels of the enterprise.
5 min read
Q319 US Hemostats and Sealants Market Recap: All Companies Post Gains
By Doug Devens on 1/6/20 12:16 PM
The US market for Hemostats and Sealants grew +5.6% YoY in Q319, a continued deceleration from +6.4% YoY in Q219, with fibrin sealants and absorbable hemostats driving the increase.
As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market experienced revenue growth in Q319. Leading the way was Becton Dickinson (BD), with Integra, Ethicon and Baxter all posting strong gains. The US Hemostats and Sealants market was up +5.6% YoY with all competitors posting gains for the quarter. Sealants continued their solid growth, up +6.5% YoY, with fibrin sealants leading the way. Absorbable hemostats resumed their leadership, contributing to the +5.1% YoY growth to...
Among the many topics covered in the complete, comprehensiveQ319 US Hemostats and Sealants Market Recap* are:
5 min read
Q319 US Infection Prevention: Antimicrobial Devices Leading the Way
By Susan Paquette on 12/20/19 11:34 AM
Positive gains in the mid-single digits for Q319, a slight decrease from previous quarter
Prevention of HAIs continues to drive measures and practices to reduce Central Line Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. In response, numerous programs and educational tools are being launched providing measures and strategies to assist healthcare providers in the prevention and reduction of infection in acute care and other settings.
Last quarter, a coalition of nurses and the AVA launched a drive to support a safety initiative for placing vascular access specialists in every hospital across America. This theme continued at this year’s AVA conference with the mission statement of “Protect the Patient, Educate the Clinician and Save the Line” highlighting the overall focus for the event. Acknowledgment of the importance of the vascular access nurse and team were featured in numerous studies and presentations demonstrating the value of the vascular access team in practice...
Among the many topics covered in the complete, comprehensive Q319 US Infection Prevention Market Recap* are:
4 min read
Q319 Advanced Wound Care Market: Strong Growth with Slower Growth Ahead?
By Susan Paquette on 12/18/19 9:45 AM
Another quarter of strong growth, but slower growth clouds building up on the horizon here and there. Both Smith+Nephew and ConvaTec have newly appointed CEOs.
For Q319, according to SmartTRAK’s Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +5.9% YoY.
Acelity remained the WW AWC market leader, up +6.3% YoY, driven by Prevena and the Crawford acquisition. WW Advanced Dressings saw several strong shifts in the ranking of companies, with ConvaTec moving up to the 2nd position, surpassing Smith + Nephew (S+N), after ConvaTec recovering, but S+N facing continued declining growth. Mölnlycke led the market and Coloplast was the strongest growing of the top four. The total market was up +3.2% YoY. US Skin/Dermal Substitute (CTP) revenue increased, with xenografts, especially Organogenesis’ PuraPly, driving gains. WW NPWT was up +8.2% YoY, with traditional devices up +3.4% and single-use...Among the many topics covered in the complete, comprehensive Q319 Advanced Wound Care Market Recap* are:
4 min read
Q319 Market Recap: US Surgical Matrices: Tepid Growth
By Doug Devens on 12/12/19 3:48 PM
The US Surgical Matrices Market grew tepidly in Q319, up +1.2% YoY, down from its +3.5% growth in Q219.
The overall US Surgical Matrices market had minimal growth for the quarter at +1.2% YoY, a decline from Q219. The Breast segment contracted -1.5% YoY and a 34.7% share of the entire Surgical Matrices market. The Hernia Repair market continued its modest growth at +2.6% YoY and a 65.3% share of the US Surgical Matrices Market in Q319.
In Q319, Allergan’s hold on the Breast Matrices segment slipped further due to supply chain issues with its AlloDerm ADM, but the Company maintained its leadership of the Surgical Matrices market a 32.3% share. BD continued its growth in their biosynthetic hernia matrices business and maintained No. 2 market position, with revenues of ...
3 min read
Day 3 Insights From Desert Foot 2019
By Terry Hayslett on 12/7/19 10:54 AM
Whether you are a patient, a provider or product manufacturer it’s difficult to make it through the day without being reminded that healthcare is expensive. Many patients see it in their rising premiums, copays and deductibles. Providers feel it when their reimbursement gets cut or is capped, and product manufacturers experience it when they hear, “it’s too expensive.”
3 min read
SmartTRAK's Top 3 Takeaways from Day 2 of Desert Foot
By Terry Hayslett on 12/6/19 9:36 AM
I’ll be the first to admit that I am not a New England Patriots fan. As a matter of fact I get rather irritated when they win year after year. Nevertheless, it’s hard to not appreciate the spirit of teamwork that has propelled the Patriots organization to win six Super Bowl titles. As we know, teamwork does not suggest the absence of conflict; however, it does express the willingness of a group of people, with individual talents, to work together to achieve a goal. Teamwork between clinicians, policy representatives and product manufacturers is crucial to winning the battle of healing wounds, salvaging limbs and saving lives. Three key takeaways from Day 2 of Desert Foot 2019 lend support to this point.
2 min read
Desert Foot 2019: Reflections From Day 1
By Terry Hayslett on 12/5/19 10:37 AM
Clinical thought-leaders and product developers convened in the heart of downtown Phoenix, Arizona at Desert Foot 2019 to share knowledge and showcase innovative technologies that aim to improve the quality of life of patients with lower extremity disorders. As a demonstration of the eagerness and commitment to share knowledge, Day 1 began bright and early at 6:00 am with a session highlighting cases in limb preservation and ended at 6:45 pm with a session questioning if there was a resurgence in amputations in patients with diabetic foot. Whether planned or not, this was a thoughtful way to bookend the day by emphasizing the potential good and bad outcomes of this vulnerable patient population...
2 min read
Desert Foot 2019: An Interview with Dr. Michael Shore
By Terry Hayslett on 12/3/19 9:47 PM
Ahead of the Desert Foot conference, SmartTRAK interviewed Dr. Michael Shore, Director of Medical Education and a founding member of PRESENT e-Learning Systems, to preview the conference which is being held Dec 4-7, 2019 in Phoenix, AZ
The multi-specialty conference provides comprehensive education for the overall management of the high-risk foot and lower extremities for podiatrists and other clinicians. Attendees will benefit from a wide variety of presentations, hands-on workshops and scientific research and will see cutting edge technology presented by the largest medical device and pharmaceutical companies in the industry.
To find our more about Desert Foot 2019, as well as PRESENT e-learning Systems, click on the following video to listen to SmartTRAK’s interview with Dr. Shore. (16:45 min)